Clinical Trials
at Overlook Medical Center
at Overlook Medical Center
The next generation of brain tumor treatments.
At the Glasser Brain Tumor Center, we’re extremely proud to have a robust clinical trial research program that is advancing novel brain tumor treatments and offers patients hope. These clinical trials include:
- The “SURVIVE” Phase 2B trial of a first-of-its-kind brain cancer vaccine for patients with newly diagnosed glioblastoma
- A study of Berubicin – one of the first chemotherapy drugs to cross the blood-brain tumor barrier and overcome drug resistance – in adults with recurrent glioblastoma multiforme
- The ongoing development of novel treatments including immunotherapies, brain tumor vaccine strategies, oncolytic tumor viruses and other targeted therapies for high-grade primary brain tumors, low-grade gliomas, metastatic brain tumors and more.
If you’re interested in learning more about specific clinical trials that are underway and enrollment, please visit Atlantic Health System or call 908.522.5768.
- Genetic Testing in Guiding Treatment for Patients With Brain Metastases
- Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
- Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
- Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- Radiation Therapy in Treating Young Patients With Gliomas